Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Testosterone may both worsen and protect against COVID-19 effects in men.

Some skin diseases and their treatments can negatively affect male fertility.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

Finasteride doesn't affect oral testosterone undecanoate, and high DHT levels may cause acne, prostate issues, and hair loss.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Finasteride can cause muscle pain and high creatine kinase levels, but stopping the medication may resolve symptoms.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Transvaginal hydrolaparoscopy is effective for increasing ovulation and pregnancy rates in women with PCOS who didn't respond to clomiphene.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Finasteride affects frog testes by increasing testosterone, decreasing 5α-DHT, and impacting genes related to reproduction and other functions.

Finasteride negatively affects fish reproduction and gonadal development.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Ficus carica extract improved fertility in rats and may help with certain health conditions.